Latest Commercialisation News

InVert Graphite has secured full ownership of RapidGraphite, gaining exclusive rights to RapidPulse technology that promises to transform graphite processing with a rapid, sustainable method. The company raised A$2.5 million to fund scaled-up trials, aiming to integrate this breakthrough with its Tanzanian graphite assets.

Parkway Corporate has cleared major regulatory hurdles for its Queensland Brine Management Complex, the first Australian facility authorised to convert coal seam gas waste brine into industrial chemicals, setting a new benchmark in sustainable waste management.

Botala Energy reports promising early gas observations at its Serowe-3.5B well in Botswana, signaling reservoir responsiveness as the well approaches a critical dewatering stage in its Pitse Pilot.

Motio Ltd (ASX:MXO) reported a solid FY26 with revenue rising to $9.2 million, a 31% jump in cash EBITDA to $2.5 million, and a net profit before tax of $1.7 million. The company enters FY27 debt free and with forward revenue up 28%, signalling operational leverage and growth potential.

AnteoTech has formalised a strategic alliance with South Korea’s Xerabrid to co-develop and commercialise a breakthrough battery separator combining their proprietary technologies, targeting high-performance applications in eVTOL, EVs, and consumer electronics.

Sparc Technologies launches a $2.5 million capital raise via a Share Purchase Plan and placement to fast-track commercial rollout of its graphene additive ecosparc® and support green hydrogen scale-up.

Zinc of Ireland (ASX: ZMI) has fast-tracked its ARGO technology development to recover germanium, gallium, and indium, targeting early 2027 for pilot plant operations. The move aligns with EU regulatory demands for critical minerals and aims to reduce waste and emissions in zinc smelting.

Dimerix has received a US$10 million upfront payment from Everest Medicines under a regional licensing deal for DMX-200 targeting FSGS in Greater China, South Korea and Southeast Asia. This deal marks Dimerix’s fifth commercial partnership for DMX-200, collectively worth up to A$1.9 billion in milestones and royalties.

Memphasys has cleared a key regulatory hurdle in Vietnam for its Felix™ System, prompting a significant first commercial cartridge order and marking early clinical success in a fast-growing fertility market.

Ridley Corporation’s FY26 results reveal a dramatic revenue surge fueled by its Incitec Pivot Fertilisers acquisition, alongside a significant profit drop due to a $31.8 million impairment on NovaqPro® and acquisition costs. The company declares a higher fully franked dividend, signaling confidence despite challenges.

Mount Ridley Mines has lodged a provisional patent for its SelectroTM hydrometallurgical leach technology, demonstrating superior recoveries of rare earths, scandium, and gallium compared to conventional methods. The company is advancing testwork and commercial discussions to capitalise on the innovation.

Atomo Diagnostics has appointed Dr Cheri Walker as interim CEO, replacing founder John Kelly who steps down after 15 years. The leadership change aligns with the company's shift towards commercial growth in the US and Europe.